On December 30, 2024, the Massachusetts state legislature passed House Bill 4653 (the Act), which significantly enhances ...
JMP Securities has recently raised Sabra Health Care REIT Inc (SBRA) stock to Mkt Outperform rating, as announced on January 7, 2025, according to Finviz. Earlier, on December 5, 2024, Mizuho had ...
Fintel reports that on January 7, 2025, JMP Securities upgraded their outlook for Sabra Health Care REIT (NasdaqGS:SBRA) from ...
Health Care REITs LTC Properties (LTC) and Sabra Health Care REIT (SBRA) were upgraded at JMP, citing multiple tailwinds are ...
JMP Securities upgraded Sabra Health Care (SBRA) to Outperform from Market Perform with a $20 price target The firm expects “multiple ...
In a report released today, Aaron Hecht from JMP Securities upgraded Sabra Healthcare REIT (SBRA – Research Report) to a Buy, with a price ...
Sabra Health Care REIT rated buy, undervalued compared to peers. Investment-grade ratings, +7% dividend yield opportunity.